Shah Rukh Khan‘s Dunki has successfully completed a fortnight in theatres. As per industry tracking website Sacnilk, Dunki’s box office on Friday (January 5) was Rs 2.20 crore, taking its total India nett earnings to Rs 208.67 crore. According to the film’s production house, Red Chillies Entertainment, director Rajkumar Hirani’s has earned Rs 422.99 crore at the global box office, which means that it will overtake Chennai Express’ Rs 423 crore lifetime gross today to become the third-biggest hit of SRK’s career behind Jawan and Pathaan. Incidentally, each of these films was released in 2023.
Also starring Taapsee Pannu and Vikcy Kaushal, Dunki is holding well at the box office, but it hasn’t been able to match the lifetime box office performance of Hirani’s earlier films, like the Ranbir Kapoor-starrer Sanju, which made Rs Rs 588 crore worldwide during its theatrical run in 2017, and Aamir Khan’s PK (2014) whose total gross was Rs 769.89 crore.
View this post on Instagram
A post shared by Red Chillies Entertainment (@redchilliesent)
Crossing the Rs 500 crore mark at the global box office will be difficult for Dunki, as two new films are releasing this month — Katrina Kaif and Vijay Sethupathi’s Merry Christmas (releasing on January 12) and Deepika Padukone and Hrithik Roshan’s Fighter (releasing on January 25). The last Rajkumar Hirani film to earn under Rs 500 crore worldwide is 3 Idiots, which was released in 2009.
View this post on Instagram
A post shared by PVR Cinemas (@pvrcinemas_official)
SRK, who made a stupendous comeback to the big screen with two of the biggest earning films in the history of Hindi films — Pathaan and Jawan, has not yet announced his next project. However, reports suggest that he’ll be seen doing a long cameo in Sujoy Ghosh’s next, starring his daughter, Suhana Khan.
Click for more updates and latest Bollywood news along with Entertainment updates. Also get latest news and top headlines from India and around the world at The Indian Express.
Disclaimer: The copyright of this article belongs to the original author. Reposting this article is solely for the purpose of information dissemination and does not constitute any investment advice. If there is any infringement, please contact us immediately. We will make corrections or deletions as necessary. Thank you.
